The AI workspace for legal professionals

  • Legal research with access to more than 1 million sources
  • Document automation
  • Matter management
  • Hosted in the EU and Switzerland

Try it free for 14 days (10 questions/day during trial)

Try for freeBook a demo
Back to law

Art. 62b

812.21TPAFederal ActJan 1, 2002Original source
  1. The Agency and the Federal Office for Customs and Border Security (FOCBS), after weighing up the interests, are entitled on a case-by-case basis to disclose confidential data collected in accordance with this Act to the holder of an operating licence or of a marketing authorisation for medicinal products or to any person who places a medical device on the market, including sensitive personal data in accordance with Article 5 letter c number 5 of the Data Protection Act of 25 September 20201, provided this measure is regarded as necessary in order to uncover or combat suspected illegal trading in therapeutic products.2
  2. Personal data relating to patients may not be disclosed.

Footnotes

  1. SR 235.1 ↩

  2. Amended by Annex 1 No II 74 of the Data Protection Act of 25 Sept. 2020, in force since 1 Sept. 2023 (AS 2022 491;BBl 2017 6941). ↩

0 commentaries

No commentaries are available for this article yet.

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.